The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in ...
Mill Valley, CA – April 15, 2026 – CURE SYNGAP1, the premier global patient advocacy group dedicated to transforming the lives of those living with SYNGAP1-Related Disorders (SRD), today announced ...
Researchers at Children's Hospital of Philadelphia (CHOP) have found that in rare instances, variants responsible for SYNGAP1-related disorders—a group of disorders characterized by developmental ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment, causing epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It is caused by mutations in ...
CAMP4 Therapeutics reports promising results for CMP-SYNGAP-01 and CMP-CPS-001 in treating genetic disorders, with favorable safety data. CAMP4 Therapeutics announced promising results from its ...
ATLANTA — June 21 is International SYNGAP1 Awareness Day, bringing awareness to a rare genetic disorder you may have never even heard of, but Atlanta parents, Suzanne and Brent Jones are working to ...
Mill Valley, CA – February 11, 2025 – The SynGAP Research Fund 501(c)(3) dba Cure SYNGAP1 proudly announces the release of its inaugural Impact Report, a transparent and celebratory reporting of ...
The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in ...
Five years ago, Hayden Cheng entered the world following a normal pregnancy and birth. Then her mom, Minnie Zhou, noticed her child wasn’t sleeping as a newborn should. “You know how people say, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results